Distribution of the Matsuda index in Japanese healthy subjects

Journal of Diabetes Investigation

Volumn 4, Issue 4, 2013, Pages 369-371

  Takahara, Mitsuyoshi ^a   Katakami, Naoto ^b   Kaneto, Hideaki ^a   Noguchi, Midori ^b   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Health Support Promotion Section   (Japan)

Author keywords

Insulin resistance; Matsuda Index; Reference limit

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; JAPANESE; MALE; MATSUDA INDEX; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; REFERENCE VALUE;

EID: 84880174528     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12056     Document Type: Article

References (15)

1. Seino Y, Nanjo K, Tajima N, et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus: The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010; 1: 212-228.
2. The Examination Committee of Criteria for the Metabolic Syndrome in Japan. Definition and diagnostic criteria of the metabolic syndrome. J Japan Soc Intern Med 2005; 94: 794-809.
3. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
4. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
5. DeFronzo RA, Matsuda M. Reduced time points to calculate the composite index. Diabetes Care 2010; 33: e93.
6. Yamada C, Mitsuhashi T, Hiratsuka N, et al. Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population. J Diabetes Invest 2011; 2: 373-376.
7. Clinical and Laboratory Standards Institute (CLSI). Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline. 3rd edn. CLSI document C28-A3. Clinical and Laboratory Standards Institute, Wayne, PA, 2008.
8. Kernan WN, Inzucchi SE, Viscoli CM, et al. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke. Stroke 2003; 34: 1431-1436.
9. Gallagher D, Visser M, De Meersman RE, et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 1997; 83: 229-239.
10. Raji A, Seely EW, Arky RA, et al. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001; 86: 5366-5371.
11. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006; 368: 1681-1688.
12. Nakai Y, Nakaishi S, Kishimoto H, et al. The threshold value for insulin resistance on homeostasis model assessment of insulin sensitivity. Diabet Med 2002; 19: 346-347.
13. Matsumoto K, Miyake S, Yano M, et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 1997; 20: 1562-1568.
14. Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643-1649.
15. Lee JM, Okumura MJ, Davis MM, et al. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care 2006; 29: 2427-2432.